Biogenic amines have been shown to play a pivotal role in mammalian development. Circulating catecholamines, released from the adrenal medulla in response to the stress of birth, evoke short-term respiratory, cardiovascular and metabolic adjustments which are essential for neonatal survival in the immediate perinatal period (I, 2). We have recently shown that, in the fetal rat, lung P-adrenergic receptors become coupled to reabsorption of lung liquid and to regulation of phosphatidic acid phosphatase (a key enzyme in surfactant synthesis) just before birth (3) . Importantly, the ability of preceptors to evoke these responses then declines after birth even though receptor binding sites increase (3, 4) , suggesting that the linkage of receptors to specific cellular events may be relatively more critical to development than is the absolute number of receptors.
The onset of noradrenergic neuronal function represents an-other phase in which transient coupling of P-receptors to a specified response is important. Development of sympathetic synaptic competence and cardiovascular reflex function is accompanied by a surge in sympathetic tone which is most notable in the second to fourth postnatal wk in the rat ( 5 , 6 ) . During this period, sympathetic input has been proposed to serve as a "switch" that reduces or terminates cell replication in favor of differentiation and cell enlargement (4, 7) . Indeed, at this point, P-receptors become highly coupled to the ability to shut off DNA synthesis in peripheral tissues, a function that is subsequently lost (4) . Concurrently, the ability of receptor activation to stimulate ODC becomes favored (3, 8, 9) . ODC initiates the synthesis of polyamines, intracellular regulators of macromolecule synthesis (10, 11): trophic hormones (including catecholamines) typically induce ODC as a prelude to enhancing RNA and protein synthesis (9) (10) (11) (12) .
In our earlier work with developing lung, we found that the ability of ,B-receptors to stimulate ODC, although detectable in the fetus, was relatively low, a factor which would tend to protect lung replication/differentiation patterns from short-term effects of the catecholamines released acutely at birth (1-4). However, at the same time, the presence of that small degree of reactivity also suggested that repeated, intense P-adrenergic stimulation could affect cellular development, a common situation when Pagonists, such as terbutaline, are used to arrest premature labor or to manage asthma. Accordingly, in the current study, we have examined the effects of late gestational treatment with terbutaline on cellular development in fetal and neonatal rat lung as well as liver, a tissue that also possesses P-receptors coupled to ODC but that undergoes high rates of cell replication much later in development. In addition to evaluating the immediate impact of drug treatment on basal tissue ODC activity, we have examined the subsequent effects on the linkage of P-receptors to ODC, and perhaps more importantly, on patterns of cell replication and differentiation (DNA, RNA, and protein).
MATERIALS AND METHODS
Timed pregnant Sprague Dawley rats (Zivic-Miller Laboratories, Allison Park, PA) were housed individually and given food and water ad libitum. On gestational d 17, 18, and 19, dams were given terbutaline (Geigy Pharmaceuticals, Ardsley, NY) at a dose of either 2 mg/kg or 10 mg/kg SC; controls received equivalent vol of saline. For prenatal studies, dams were killed by decapitation 24 h after the last dose, three fetuses were excised from each, and their tissues were pooled for analysis. After birth, pups were randomized and redistributed to the nursing dams with litter size maintained at 8-12 pups; randomization was carried out again just before each experiment, and, in addition, pups were selected from different cages and sex-matched between treatment groups. Pups were killed by decapitation, and analyses were carried out on tissues from individual animals.
All tissues were homogenized (Polytron) in 19 vol of Tris-HC1 buffer (pH 7.2), and aliquots were taken for the various assays. ODC activity was measured in the 26 000 x g supernatant solution by the method of Bartolome and Slotkin (1 3) at a final substrate concentration of 4 pM L-ornithine-[1-I4C] (New England Nuclear Corp., Boston, MA; sp act 53.1 mCi/mmol) in the presence of 50 pM pyridoxal-5'-phosphate and 1.5-mM dithiothreitol. Because acute or long-term changes in ODC activity can include induction, activation or other posttranslational modifications of the enzyme (1 3), we selected a subsaturating concentration of ornithine so as to enable detection of alterations regardless of the specific kinetic mechanism involved.
In another aliquot, extraction and analysis of DNA, RNA, and protein were carried out by standard procedures (14, 15) . Results of the macromolecule determinations were evaluated both as concentration (mg/g tissue) and content (mgltissue). These can have distinctly different meanings: for example, DNA concentration gives a measure of cell packing density, whereas DNA content assesses the total number of cells present within the specified tissue. We also used the measurements of macromolecule concentration to calculate the protein/DNA ratio, a biochemical index of relative cell size (1 4, 16).
In addition to studies of basal developmental characteristics, ODC responses to acute p-adrenergic agonist challenge were evaluated. Animals in control and terbutaline groups were given D,L-isoproterenol sulfate (2.5 mg/kg SC; Sigma Chemical Co., St. Louis, MO) or an equivalent vol (1 pL/g body wt) of vehicle and killed 4 h later, a dose and time span previously shown to be optimal for observing 0-agonist-induced increases in ODC activity (8, 17 ). Stimulation of ODC was then evaluated as the difference between values in the isoproterenol group and its corresponding saline cohort.
Data analysis and statistics. Data are presented as means and SEM. For the prenatal data, fetuses of each dam were considered to represent a single determination; thus "10 prenatal determinations" would denote fetuses analyzed from 10 different dams. For postnatal studies, the indicated number of determinations represents individual animals, which is appropriate because of the randomization procedure used after birth. Initial statistical analyses were conducted by ANOVA (data log-transformed whenever variance was heterogeneous). Longitudinal differences in tissue wt, macromolecules, and basal ODC activity were evaluated by 2-way ANOVA with factors of age and terbutaline treatment. Evaluation of acute responses to isoproterenol was canied out by 3-way ANOVA (age, terbutaline treatment, isoproterenol treatment), followed by appropriate lower-order AN-OVA where interactions of terbutaline x isoproterenol treatment or terbutaline x isoproterenol x age were found. Individual ages at which differences between control and terbutaline groups were significant were then evaluated post hoc by Duncan's multiple range test. Significance was assumed at the level o f p < 0.05. For convenience, body and tissue wt, and macromolecule concentration and content are all presented as percentages of control values; however, statistical analyses were performed only on the raw data. (Table 1) . Dams in all three treatment groups gave birth on the 22nd d of gestation. Postnatal wt gains in the pups were within normal limits in the 2 mg/kg group but did show a small initial retardation in animals exposed to the higher dose (Fig. 1) . All wt differences disappeared by the end of the second postnatal wk. Basal ODC activity and acute responses to isoproterenol. In keeping with earlier results (17, 18) , the developmental pattern of basal lung ODC in the control group displayed three characteristic phases (Fig. 2, left) . Before birth, ODC was high and then declined sharply in the immediate postnatal period. A small increase was observed during the first postnatal wk and a subsequent, larger peak of activity was evident in the 4th wk. This pattern was significantly affected by maternal terbutaline treatment: on gestational d 20 (24 h after the last terbutaline dose), activity was profoundly elevated in a dose-dependent manner, an effect which persisted into the immediate postnatal period. Prenatal terbutaline exposure also altered the later phase of rise of basal ODC, with a shift toward earlier appearance of the peak of activity (2 mg/kg group) and a blunting of the magnitude of the peak (both doses, but most prominently at 10 mg/kg).
Basal liver ODC showed little or no stimulation by terbutaline in the prenatal period immediately following drug exposure (Fig.  2, right) . However, as in the lung, the terbutaline groups displayed a premature, attenuated peak of liver enzyme activity during the 4th postnatal wk.
In control rats, responsiveness of ODC to acute challenge with isoproterenol was low at birth and rose to a maximum during the 4th postnatal wk in both lung (Fig. 3, left) and liver (Fig. 3,  right) . Animals exposed prenatally to terbutaline also displayed a peak of isoproterenol stimulation during the 4th wk. However, the treated group tended to exhibit elevated responses later on (d 43 in lung, d 33 and 43 in liver).
Tissue growth and macromolecules. In control rats, the period of greatest cell proliferation in the postnatal lung occurred during the first 2 postnatal wk and was characterized by rapid increases in DNA, RNA, and protein content (Fig. 4, left) . The subsequent cessation of cell acquisition and maintenance of tissue growth by cell enlargement was apparent by decreases in DNA concentration during the 4th postnatal wk. In contrast to the developing lung, liver DNA, RNA, and protein levels showed their most dramatic increase during the third and fourth postnatal wk (Fig.  4, right) .
As prenatal terbutaline exposure at 2 mg/kg significantly altered the developmental pattern of ODC without affecting body wt, we examined lung and liver nucleic acids and proteins at this dose. Initially, maternal terbutaline treatment caused a significant elevation in neonatal lung RNA, despite the presence of reductions in lung wt and protein (Fig. 5, left) . Subsequently, the terbutaline group exhibited deficiencies in total cell numbers (DNA content) and packing density (DNA concentration), accompanied by corresponding deficits of other macromolecules. In the liver, terbutaline exposure failed to cause an initial elevation in RNA and had a smaller effect (not statistically significant) on growth and protein levels (Fig. 5 , right) . Nevertheless, these animals developed a significant deficit in DNA and a corresponding shortfall in RNA. Fig. 2 . Effects of prenatal terbutaline administration on basal ODC activity in developing lung (I@) and liver (right), CON = control group; TER2 = terbutaline, 2 mg/kg; TER10 = terbutaline, 10 mg/kg. Data represent means and SEM of values from 7-28 rats in each treatment group at each age. ANOVA indicates significant effects of terbutaline in either tissue at both dosage levels (lung, interaction of treatment X age at 2 mg/ kg, main treatment effect and interaction of treatment x age at 10 mg/kg; liver, main treatment effect, and interaction of treatment X age at either dose). * , individual ages at which the terbutaline groups differ significantly from controls. Fig. 3 . Effects of prenatal terbutaline administration on the acute stimulatory response of ODC to P-adrenergic agonist stimulation (isoproterenol, 2.5 mg/kg). CON = control group; TER2 = terbutaline, 2 mg/kg; TERlO = terbutaline, 10 mg/kg. Basal (unstimulated) values appear in Figure 2 . Data represent means and SEM of stimulations evaluated in eight-28 rats in each treatment group at each age. In both lung (left) and liver (right), ANOVA indicates significant effects of terbutaline at either dosage level (lung, treatment x age interaction at either dose; liver, treatment x age interaction at 2 mg/kg, main treatment effect at 10 mg/kg). * , individual ages at which the terbutaline groups differ significantly from controls. Figure 4 . Data represent means and SEM of values from eight-10 rats at each age. For lung, ANOVA indicates a significant reduction in wt (main treatment effect), a deficit in DNA content and concentration (main treatment effect and treatment x age interaction), alterations in RNA content and concentration (treatment X age interaction) and in protein concentration (treatment x age interaction), and an overall lowering of protein content (main treatment effect and treatment X age interaction). There were no statistically significant effects on liver wt or DNA content, but DNA concentration was affected (treatment X age interaction). Liver RNA concentration (main treatment effect) and content (main treatment effect and treatment X age interaction) were also affected by terbutaline exposure. * , individual ages where differences were significant. 
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* Data represent m e a n s a n d SEM of values from six t o 10 rats a t each age in control (CON) a n d 2 mg/kg terbutaline (TER2) groups. A N O V A indicates n o significant treatment effect o r interaction oftreatment x age for either tissue.
Neither lung nor liver showed any significant effects of maternal terbutaline treatment on protein/DNA ratio ( Table 2 ).
DISCUSSION
Results obtained in this study support the view that, even before birth, P-adrenergic input can influence cellular development and may participate in the programming of future trophic responses of sympathetic target tissues. Despite the relative inefficiency of the coupling of fetal lung P-receptors to ODC activity, repeated stimulation with terbutaline was still able to cause a profound stimulation as seen on gestational d 20. In light of the effects on ODC and the role of P-receptors in terminating cell replication (which would ordinarily occur later, with the onset of sympathetic innervation), the eventual adverse effects of terbutaline on cell acquisition (DNA) and alterations in RNA and protein may thus be viewed as a direct consequence of premature activation of lung P-receptors. The results suggest a primary effect on cell replication, i.e. no alteration of relative cell size (protein/DNA ratio) and deficits in protein levels generally matching those for DNA.
It is notable that in the liver, a tissue where ODC was not stimulated prenatally by terbutaline, deficits in DNA were substantially smaller and no promotion of RNA or deficit of protein was seen.
The rise in basal ODC activity that ordinarily occurs in lung, liver, and other peripheral tissues toward the end of the 1st mo postpartum, is thought to represent a combined trophic influence of a variety of hormonal and neuronal regulatory factors (8, 9) . Thus, as found here, the disruption of the late peak in ODC caused by prenatal terbutaline may represent long-term interference with response capabilities of the tissue. The suppression of the peak is clearly a separable event from the direct 0-receptor stimulation in the fetus, as the same late postnatal effect was seen in the liver, a tissue which did not display fetal ODC stimulation by terbutaline. Activation of the ODC pathway by neonatal neural input has been shown to be important in determining future responsiveness to @-adrenergic stimulation (17) , and our finding that the terbutaline-exposed animals display a late phase of enhanced responsiveness to acute isoproterenol challenge is thus consistent with this role. However, it should be noted that basal ODC was suppressed long before the alteration in the isoproterenol response, suggesting that prenatal terbutaline treatment may serve to blunt trophic effects of factors other than 6-adrenergic stimulation. This possibility is undergoing active investigation in our laboratory.
